(Q33297414)

25 July 2017

title

Mesothelin, a possible target for immunotherapy, is expressed in primary AML cells (English)

1 reference

25 July 2017

1 reference

7

Bernd Gruhn

1 reference

25 July 2017

4

Kristin Dawczynski

1 reference

25 July 2017

6

Raffit Hassan

1 reference

25 July 2017

8

Ira Pastan

1 reference

25 July 2017

2

Masanori Onda

1 reference

25 July 2017

Daniel Steinbach

1

1 reference

25 July 2017

Astrid Voigt

series ordinal

3

1 reference

25 July 2017

Susan Wittig

series ordinal

5

1 reference

25 July 2017

publication date

4 September 2007

1 reference

European Journal of Haematology

25 July 2017

published in

1 reference

25 July 2017

volume

79

1 reference

25 July 2017

issue

4

1 reference

25 July 2017

page(s)

281-286

1 reference

Mesothelin: a new target for immunotherapy

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00928.X

Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00928.X

The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00928.X

The use of housekeeping genes for real-time PCR-based quantification of fusion gene transcripts in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00928.X

Identification of a set of seven genes for the monitoring of minimal residual disease in pediatric acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00928.X

New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00928.X

MESOMARK: a potential test for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00928.X

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00928.X

Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00928.X

Mesothelin expression in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00928.X

Mesothelin Is Shed from Tumor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00928.X

10.1111/J.1600-0609.2007.00928.X

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference